ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 0262

SLE Pregnancies: C4 as Predictor of Flares and Adverse Pregnancy Outcomes

Francesca Crisafulli1, Laura Andreoli1, Matteo Filippini1, Micaela Fredi1, Maria Chiara Gerardi1, Roberto Gorla2, Maria Grazia Lazzaroni1, Daniele Lini1, Cecilia Nalli2, Marco Taglietti1, Andrea Lojacono3, Sonia Zatti3, Cristina Zanardini3, Franco Franceschini1 and Angela Tincani1, 1Rheumatology and Clinical Immunology Unit, Spedali Civili and University of Brescia, Brescia, Lombardia, Italy, 2Rheumatology and Clinical Immunology Unit, ASST Spedali Civili of Brescia, Brescia, Lombardia, Italy, 3Obstetrics and Gynecology Unit, Spedali Civili and University of Brescia, Brescia, Lombardia, Italy

Meeting: ACR Convergence 2020

Keywords: complement, pregnancy, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Date: Friday, November 6, 2020

Session Title: SLE – Diagnosis, Manifestations, & Outcomes Poster I: Clinical Manifestations

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: SLE pregnancies have an increased risk of Adverse Pregnancy Outcomes (APO). In clinical practice, low C3 and C4 levels are associated with active disease and, during pregnancy, complement activation products are shown to be associated with APO. Our aim was to analyse C3 and C4 variations during SLE pregnancies, focusing on APO and disease flares.

Methods:

Data on SLE pregnancies prospectively-followed by a multidisciplinary team from 1987 to 2017 were analysed. Serum C3 and C4 levels were recorded at preconception visit (T0) and each trimester (T1, T2, T3). Hypocomplementemia was defined according to the normality range calculated in healthy pregnancies by Reggia et al. APO were defined as: early miscarriage (< 10thweek), intrauterine fetal death (IFD, >10thweek), perinatal death (< 30thday of life), pre-eclampsia (PE), severe preterm birth (< 34thweek).

Results: 153 pregnancies in 106 SLE patients were analysed. APO occurred in 25 (16%): 13 early miscarriages, 4 IFD, 3 severe preterm births, 7 PE (hesitated in 2 IFD and 7 live births); 13 flares (2 renal, 4 articular, 6 cutaneous and 1 neurological) were recorded in 11 (7%) pregnancies.

In pregnancies with flares C3 was lower at T2 and T3 as compared with pregnancies without flare while C4 was lower at T0 and T3 (fig 1). There was no difference between pregnancies with and without APO.

Considering the overall pregnancies, C3 progressively increased from T0 to T3, while it remained stable between T2-T3 in the flare group and between T0-T1 and T2-T3 in the APO group (tab1). 
In the flare group, C4 increased only between T0-T1 while in the APO group it remained stable throughout pregnancy. Notably, in pregnancies without APO, C4 increased from T0 to T2.

In pregnancies with APO, the variation of C4 levels between T2-T3 trimester was lower than in pregnancies without APO (mean: -2.98 [SD 0.05] vs 0,4 [SD 3.05]; p=0.03).

The frequency of low C4 was higher in pregnancies with flare at T0 and at each trimester as compared with pregnancies without flares (tab2).

Conclusion: Low C4 at pre-conceptional visit seems to predict flares during pregnancy. Lower increase of C4 levels between the 2nd and the 3rdtrimester could predict APO.


Disclosure: F. Crisafulli, None; L. Andreoli, None; M. Filippini, None; M. Fredi, None; M. Gerardi, None; R. Gorla, None; M. Lazzaroni, None; D. Lini, None; C. Nalli, None; M. Taglietti, None; A. Lojacono, None; S. Zatti, None; C. Zanardini, None; F. Franceschini, None; A. Tincani, None.

To cite this abstract in AMA style:

Crisafulli F, Andreoli L, Filippini M, Fredi M, Gerardi M, Gorla R, Lazzaroni M, Lini D, Nalli C, Taglietti M, Lojacono A, Zatti S, Zanardini C, Franceschini F, Tincani A. SLE Pregnancies: C4 as Predictor of Flares and Adverse Pregnancy Outcomes [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/sle-pregnancies-c4-as-predictor-of-flares-and-adverse-pregnancy-outcomes/. Accessed January 27, 2021.
  • Tweet
  • Email
  • Print
Save to PDF

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sle-pregnancies-c4-as-predictor-of-flares-and-adverse-pregnancy-outcomes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.